World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
73
Citations
33318
World Ranking
19535
National Ranking
1758

Overview

Jeremy D. Sanderson is affiliated with Guy's and St Thomas' NHS Foundation Trust in the United Kingdom. Their research contributions focus primarily on the fields of Medicine and Biochemistry, Genetics and Molecular Biology, with a strong emphasis on subfields such as Epidemiology, Genetics, Surgery, Immunology, and Oncology.

The scientist's main topics of work center around Inflammatory Bowel Disease, Microscopic Colitis, T-cell and B-cell Immunology, Immune Cell Function and Interaction, Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, and the Diagnosis and treatment of tuberculosis.

Their recent publications include:

  • Real-world Effectiveness of Tofacitinib for Moderate to Severe Ulcerative Colitis: A Multicentre UK Experience (2020), Journal of Crohn's and Colitis
  • Human marginal zone B cell development from early T2 progenitors (2020), The Journal of Experimental Medicine
  • Tofacitinib in Acute Severe Ulcerative Colitis-A Real-World Tertiary Center Experience (2020), Inflammatory Bowel Diseases
  • A retrospective cohort study: pre-operative oral enteral nutritional optimisation for Crohn's disease in a UK tertiary IBD centre (2022), Alimentary Pharmacology & Therapeutics
  • Therapeutic thresholds for golimumab serum concentrations during induction and maintenance therapy in ulcerative colitis: results from the GO-LEVEL study (2020), Alimentary Pharmacology & Therapeutics

Jeremy D. Sanderson frequently publishes in several notable venues, including:

  • Journal of Crohn's and Colitis
  • Alimentary Pharmacology & Therapeutics
  • BMC Gastroenterology
  • Frontline Gastroenterology
  • bioRxiv (Cold Spring Harbor Laboratory)

The scientist collaborates extensively with a number of frequent co-authors in their research work. These include Joel Mawdsley, Shuvra Ray, Mark Samaan, Sailish Honap, and Peter M. Irving.

Best Publications

  • Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

    Paul R. Burton;David G. Clayton;Lon R. Cardon;Nick Craddock

  • Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease

    Luke Jostins;Stephan Ripke;Rinse K Weersma;Richard H Duerr

  • Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

    Andre Franke;Dermot P B McGovern;Jeffrey C. Barrett;Kai Wang

  • British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults

    Christopher Andrew Lamb;Christopher Andrew Lamb;Nicholas A Kennedy;Tim Raine;Philip Anthony Hendy;Philip Anthony Hendy

  • Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47.

    Carl A. Anderson;Gabrielle Boucher;Charlie W. Lees;Andre Franke

  • Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease

    Katrina M de Lange;Loukas Moutsianas;James C Lee;Christopher A Lamb

  • Genome-wide association study identifies eight loci associated with blood pressure

    Christopher Newton-Cheh;Christopher Newton-Cheh;Toby Johnson;Toby Johnson;Vesela Gateva;Martin D. Tobin

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility.

    Miles Parkes;Jeffrey C Barrett;Natalie J Prescott;Mark Tremelling

  • Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls

    Nick Craddock;Matthew E. Hurles;Niall Cardin;Richard D. Pearson

  • High-throughput clone library analysis of the mucosa-associated microbiota reveals dysbiosis and differences between inflamed and non-inflamed regions of the intestine in inflammatory bowel disease

    Alan W Walker;Jeremy D Sanderson;Carol Churcher;Gareth C Parkes

  • The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease

    Andrew P. Cuthbert;Sheila A. Fisher;Muddassar M. Mirza;Kathy King

  • Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A

    Sergey Nejentsev;Joanna M. M. Howson;Neil M. Walker;Jeffrey Szeszko

  • Review article: lactose intolerance in clinical practice--myths and realities.

    M C E Lomer;G C Parkes;Jeremy Sanderson;Jeremy Sanderson

  • Genome-wide association study of ulcerative colitis identifies three new susceptibility loci, including the HNF4A region

    Jeffrey C Barrett;James C Lee;Charles W Lees;Natalie J Prescott

  • Genetic determinants of ulcerative colitis include the ECM1 locus and five loci implicated in Crohn's disease

    Sheila A Fisher;Mark Tremelling;Carl A Anderson;Rhian Gwilliam

  • Randomised, double-blind, placebo-controlled trial of fructo-oligosaccharides in active Crohn's disease

    Jane L Benjamin;Charlotte R H Hedin;Andreas Koutsoumpas;Siew C Ng;Siew C Ng

  • A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5.

    Natalie J. Prescott;Sheila A. Fisher;Andre Franke;Jochen Hampe

  • Adverse drug reactions to azathioprine therapy are associated with polymorphism in the gene encoding inosine triphosphate pyrophosphatase (ITPase).

    Anthony M Marinaki;Azhar Ansari;John A Duley;Monica Arenas

  • Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data

    Didier Meulendijks;Linda M Henricks;Gabe S Sonke;Maarten J Deenen

Frequent Co-Authors

Christopher G. Mathew
Christopher G. Mathew King's College London
Cathryn M. Lewis
Cathryn M. Lewis King's College London
Natalie J. Prescott
Natalie J. Prescott King's College London
Alastair Forbes
Alastair Forbes University of Tartu
Stephen Challacombe
Stephen Challacombe King's College London
Miles Parkes
Miles Parkes University of Cambridge
Jack Satsangi
Jack Satsangi University of Oxford
Stefan Schreiber
Stefan Schreiber Kiel University
Derek P. Jewell
Derek P. Jewell University of Oxford
Jo Spencer
Jo Spencer King's College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond the traditional MD route, there are numerous flexible and affordable online options. Many students are choosing pathways in healthcare administration or advanced nursing due to high demand and excellent growth prospects.

Prospective nurses might explore the shortest pmhnp program options to become Psychiatric-Mental Health Nurse Practitioners quickly. This allows for a faster transition into advanced clinical roles.

For those interested in leadership, health administration degrees online are rising in popularity. These can lead to rewarding careers in hospital management or allied health services.

Affordability is a key concern for many students. Comparing the masters in healthcare administration cost and searching for cheap online dnp programs can help reduce financial barriers while maximizing your long-term career potential.

These alternative online degrees expand your options, giving you more ways to make a difference in healthcare—without the lengthy commitment or high expense of traditional medical school.

Best Scientists Citing Jeremy D. Sanderson

Trending Scientists